[BRIEFING.COM] The S&P 500 (-0.1%) holds a modest loss for the day, while the DJIA (+0.1%) outperforms and the Nasdaq Composite (-0.4%) lags the group.
Seven sectors trade in the green at this juncture, led by the health care sector (+1.4%).
The health care sector's top component, Eli Lilly (LLY 776.25, +14.07, +1.9%), is seeing some gains following initial reports that the presymptomatic Alzheimer's trial, TRAILBLAZER-ALZ 3, could see an interim analysis sooner than investors expect, potentially by the start of 4Q25, according to BMO's David Seigerman.
After posting a 0.6% loss yesterday, the majority of health care components are in positive territory today, with IQVIA (IQV 184.27, +25.31, +15.9%) trading sharply higher after beating EPS expectations by $0.04, beating on revenues, guiding FY25 EPS in-line, and guiding FY25 revenues above consensus.